ImageneBio (IMA) Total Liabilities (2020 - 2025)

ImageneBio has disclosed Total Liabilities across 6 years of filings, most recently posting $19.8 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 13.69% year-over-year to $19.8 million; the TTM figure through Dec 2025 stood at $19.8 million (up 13.69% YoY), while the FY2025 annual figure was $19.8 million, up 13.69% from the prior year.
• Total Liabilities came in at $19.8 million for Q4 2025 at ImageneBio, down from $21.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $66.0 million in Q1 2021 to a low of $10.3 million in Q2 2025.
• Average Total Liabilities over 5 years is $28.3 million, with a median of $21.7 million recorded in 2023.
• Year-over-year, Total Liabilities sank 59.08% in 2023 and soared 42.63% in 2025.
• Over 5 years, Total Liabilities stood at $40.0 million in 2021, then plunged by 36.78% to $25.3 million in 2022, then fell by 11.68% to $22.3 million in 2023, then retreated by 21.88% to $17.4 million in 2024, then rose by 13.69% to $19.8 million in 2025.
• Per Business Quant data, the three most recent Total Liabilities figures were $19.8 million in Q4 2025, $21.0 million in Q3 2025, and $10.3 million in Q2 2025.